228 related articles for article (PubMed ID: 10762162)
1. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
Blaes F; Beeson D; Plested P; Lang B; Vincent A
Ann Neurol; 2000 Apr; 47(4):504-10. PubMed ID: 10762162
[TBL] [Abstract][Full Text] [Related]
2. Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement.
Scuderi F; Marino M; Colonna L; Mannella F; Evoli A; Provenzano C; Bartoccioni E
Lab Invest; 2002 Sep; 82(9):1139-46. PubMed ID: 12218074
[TBL] [Abstract][Full Text] [Related]
3. Modulation of acetylcholine receptor expression in seronegative myasthenia gravis.
Poea S; Guyon T; Bidault J; Bruand C; Mouly V; Berrih-Aknin S
Ann Neurol; 2000 Nov; 48(5):696-705. PubMed ID: 11079532
[TBL] [Abstract][Full Text] [Related]
4. Anti-acetylcholine receptor (AChR) antibodies measurement in myasthenia gravis: the use of cell line TE671 as a source of AChR antigen.
Somnier FE
J Neuroimmunol; 1994 Apr; 51(1):63-8. PubMed ID: 8157737
[TBL] [Abstract][Full Text] [Related]
5. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
[TBL] [Abstract][Full Text] [Related]
6. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
Farrugia ME; Bonifati DM; Clover L; Cossins J; Beeson D; Vincent A
J Neuroimmunol; 2007 Apr; 185(1-2):136-44. PubMed ID: 17335909
[TBL] [Abstract][Full Text] [Related]
7. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
Leite MI; Jacob S; Viegas S; Cossins J; Clover L; Morgan BP; Beeson D; Willcox N; Vincent A
Brain; 2008 Jul; 131(Pt 7):1940-52. PubMed ID: 18515870
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of anti-acetylcholine receptor antibody using human rhabdomyosarcoma cell line].
Ito R; Ishiguro Y; Tetsumoto T; Harada H; Takanashi N; Oka M; Shindo Y; Yamauchi S; Ishigami T; Ohta K
Rinsho Byori; 1995 Apr; 43(4):402-8. PubMed ID: 7739124
[TBL] [Abstract][Full Text] [Related]
9. A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines.
Keefe D; Hess D; Bosco J; Tzartos S; Powell J; Lamsa J; Josiah S
Cytometry B Clin Cytom; 2009 May; 76(3):206-12. PubMed ID: 18825779
[TBL] [Abstract][Full Text] [Related]
10. Measurement of anti-acetylcholine receptor auto-antibodies in myasthenia gravis.
Steenkamp KJ; Duim W; Myer MS; Malfeld SC; Anderson R
S Afr Med J; 1995 Dec; 85(12):1293-4. PubMed ID: 8600588
[TBL] [Abstract][Full Text] [Related]
11. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor.
Vernet-der Garabedian B; Lacokova M; Eymard B; Morel E; Faltin M; Zajac J; Sadovsky O; Dommergues M; Tripon P; Bach JF
J Clin Invest; 1994 Aug; 94(2):555-9. PubMed ID: 8040310
[TBL] [Abstract][Full Text] [Related]
12. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
[TBL] [Abstract][Full Text] [Related]
13. Seronegative myasthenia gravis.
Vincent A; McConville J; Farrugia ME; Newsom-Davis J
Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
[TBL] [Abstract][Full Text] [Related]
14. AChR phosphorylation and indirect inhibition of AChR function in seronegative MG.
Plested CP; Tang T; Spreadbury I; Littleton ET; Kishore U; Vincent A
Neurology; 2002 Dec; 59(11):1682-8. PubMed ID: 12473752
[TBL] [Abstract][Full Text] [Related]
15. Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis.
Li Z; Forester N; Vincent A
J Neuroimmunol; 1996 Feb; 64(2):179-83. PubMed ID: 8632060
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation.
Spreadbury I; Kishore U; Beeson D; Vincent A
J Neuroimmunol; 2005 May; 162(1-2):149-56. PubMed ID: 15833370
[TBL] [Abstract][Full Text] [Related]
19. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.
Zhang B; Tzartos JS; Belimezi M; Ragheb S; Bealmear B; Lewis RA; Xiong WC; Lisak RP; Tzartos SJ; Mei L
Arch Neurol; 2012 Apr; 69(4):445-51. PubMed ID: 22158716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
